Search research articles
Contact Us
Filters
Showing results (101-110 of 163) with videos related to
Page
of 17
Sort By:
Brain, Behavior, and Immunity
|
December 20, 2000
Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice
M S Flint, D B Miller, S S Tinkle
Virology
|
December 1, 1982
Synthesis of vaccinia virus thymidine kinase in microinjected Xenopus oocytes
D E Hruby, D B Miller, L A Ball
Neuroscience Letters
|
September 14, 1990
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP
J P O'Callaghan, D B Miller, J F Reinhard
The Gerontologist
|
January 1, 1972
Nurse-physician communication in a nursing home setting
D B Miller, J Brimigion, D Keller, et al.
Annals of the New York Academy of Sciences
|
November 21, 2000
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure
D B Miller, J P O'Callaghan, S F Ali
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Journal of the South African Veterinary Association
|
June 1, 1997
Multiple malignant meningiomas in a young cat
R G Lobetti, J W Nesbit, D B Miller
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Addiction Biology
|
June 26, 2010
Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimen
D B Miller, J P O'Callaghan, E A Johnson
Addiction Biology
|
June 26, 2010
Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigens
J P O'Callaghan, D B Miller, K R Pennypacker
Page
of 17
Search research articles
Search
Showing results (101-110 of 163) with videos related to
Sort By:
Page
of 17
Brain, Behavior, and Immunity
|
December 20, 2000
Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice
M S Flint, D B Miller, S S Tinkle
Virology
|
December 1, 1982
Synthesis of vaccinia virus thymidine kinase in microinjected Xenopus oocytes
D E Hruby, D B Miller, L A Ball
Neuroscience Letters
|
September 14, 1990
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP
J P O'Callaghan, D B Miller, J F Reinhard
The Gerontologist
|
January 1, 1972
Nurse-physician communication in a nursing home setting
D B Miller, J Brimigion, D Keller, et al.
Annals of the New York Academy of Sciences
|
November 21, 2000
Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure
D B Miller, J P O'Callaghan, S F Ali
Brain Research
|
July 5, 1990
Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
J P O'Callaghan, D B Miller, J F Reinhard
Journal of the South African Veterinary Association
|
June 1, 1997
Multiple malignant meningiomas in a young cat
R G Lobetti, J W Nesbit, D B Miller
Neuroscience Letters
|
December 19, 1988
The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury
J F Reinhard, D B Miller, J P O'Callaghan
Addiction Biology
|
June 26, 2010
Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic damage induced by a neurotoxic regimen
D B Miller, J P O'Callaghan, E A Johnson
Addiction Biology
|
June 26, 2010
Chronic dopaminergic signaling in the basal ganglia: a damage perspective on kinases and fos-related antigens
J P O'Callaghan, D B Miller, K R Pennypacker
Page
of 17